2,534
Views
127
CrossRef citations to date
0
Altmetric
Review Article

Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories

, , &
Pages 143-153 | Received 09 Jun 2011, Accepted 17 Jun 2011, Published online: 29 Aug 2011

References

  • Franco RS. The measurement and importance of red cell survival. Am J Hematol 2009;84:109–114.
  • Palis J, Segel GB. Developmental biology of erythropoiesis. Blood Rev 1998;12:106–114.
  • Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, Vassault AJ, Plebani M. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764–772.
  • Sciacovelli L, Plebani M. The IFCC Working Group on laboratory errors and patient safety. Clin Chim Acta 2009;404:79–85.
  • Global Preanalytical Scientific Committee. Available at: http://www.specimencare.com. Last accessed: 22 June 2011.
  • Global Preanalytical Scientific Committee. In vitro hemolysis: causes, prevalence, effects, measurement & solutions. Available at: http://www.specimencare.com/resource.aspx?IDX=11331. Last accessed: 22 June 2011.
  • Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000;46:306–307.
  • Salvagno GL, Lippi G, Bassi A, Poli G, Guidi GC. Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory. J Eval Clin Pract 2008;14:351–353.
  • Burns ER, Yoshikawa N. Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists. Lab Med 2002;33:378–380.
  • Lippi G, Salvagno GL, Favaloro EJ, Guidi GC. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement. Clin Chem Lab Med 2009;47:616–618.
  • Hashimoto C. Autoimmune hemolytic anemia. Clin Rev Allergy Immunol 1998;16:285–295.
  • Bessler M, Schaefer A, Keller P. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology. Transfus Med Rev 2001;15:255–267.
  • Chiao EY, Engels EA, Kramer JR, Pietz K, Henderson L, Giordano TP, Landgren O. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med 2009;169:357–363.
  • Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258–271.
  • Packman CH. Hemolytic anemia due to warm autoantibodies. Blood Rev 2008;22:17–31.
  • Mayer B, Yürek S, Kiesewetter H, Salama A. Mixed-type autoimmune hemolytic anemia: differential diagnosis and a critical review of reported cases. Transfusion 2008;48:2229–2234.
  • Tabbara IA. Hemolytic anemias. Diagnosis and management. Med Clin North Am 1992;76:649–668.
  • Packman CH, Leddy JP. Acquired hemolytic anemia due to warm-reacting autoantibodies. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw Hill; 1995:667–684.
  • Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 2007;39:555–561.
  • Packman CH, Leddy JP. Cryopathic hemolytic syndromes. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw Hill; 1995:685–690.
  • Beutler E. Hemolytic anemia due to infections with microorganisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw Hill; 1995:674–676.
  • Packman CH, Leddy JP. Drug-related immune hemolytic anemia. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw Hill; 1995:691–696.
  • Beutler E. Hemolytic anemia due to chemical and physical agents. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw Hill; 1995:670–673.
  • Wright MS. Drug-induced hemolytic anemias: increasing complications to therapeutic interventions. Clin Lab Sci 1999;12:115–118.
  • Martinez J. Microangiopathic hemolytic anemia. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw Hill; 1995:669.
  • George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989–2007). Kidney Int Suppl 2009;75:S8–S10.
  • Mecozzi G, Milano AD, De Carlo M, Sorrentino F, Pratali S, Nardi C, Bortolotti U. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg 2002;123:550–556.
  • Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480–487.
  • Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol 2002;9:101–106.
  • Beutler E. G6PD: population genetics and clinical manifestations. Blood Rev 1996;10:45–52.
  • Mehta A, Mason PJ, Vulliamy TJ. Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol 2000;13:21–38.
  • Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 2004;126:455–474.
  • McCormick DJ, Atassi MZ. Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem 1990;9:735–742.
  • Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198–201.
  • Ideguchi H, Ishikawa A, Futata Y, Yamada Y, Ono Y, Sugisaki S, Hamasaki N. A comprehensive scheme for the systematic investigation of hemolytic anemia. Ann Clin Lab Sci 1994;24:412–421.
  • Garratty G. Immune hemolytic anemia associated with negative routine serology. Semin Hematol 2005;42:156–164.
  • Lippi G, Meschi T, Cervellin G. Inflammatory biomarkers for the diagnosis, monitoring and follow-up of community-acquired pneumonia: Clinical evidence and perspectives. Eur J Intern Med 2011; doi:10.1016/j.ejim.2011.02.023.
  • Ong ME, Chan YH, Lim CS. Reducing blood sample hemolysis at a tertiary hospital emergency department. Am J Med 2009;122:1054.e1–e6.
  • Lowe G, Stike R, Pollack M, Bosley J, O’Brien P, Hake A, Landis G, Billings N, Gordon P, Manzella S, Stover T. Nursing blood specimen collection techniques and hemolysis rates in an emergency department: analysis of venipuncture versus intravenous catheter collection techniques. J Emerg Nurs 2008;34:26–32.
  • Kennedy C, Angermuller S, King R, Noviello S, Walker J, Warden J, Vang S. A comparison of hemolysis rates using intravenous catheters versus venipuncture tubes for obtaining blood samples. J Emerg Nurs 1996;22:566–569.
  • Grant MS. The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples. J Emerg Nurs 2003;29:116–121.
  • Dugan L, Leech L, Speroni KG, Corriher J. Factors affecting hemolysis rates in blood samples drawn from newly placed IV sites in the emergency department. J Emerg Nurs 2005;31:338–345.
  • Halm MA, Gleaves M. Obtaining blood samples from peripheral intravenous catheters: best practice? Am J Crit Care 2009;18:474–478.
  • Plebani M, Lippi G. Hemolysis index: quality indicator or criterion for sample rejection? Clin Chem Lab Med 2009;47:899–902.
  • Simundic AM, Topic E, Nikolac N, Lippi G. Hemolysis detection and management of hemolysed specimens. Biochem Med 2010;20:154–159.
  • Thomas L. Haemolysis as influence and interference factor. eJIFCC 13(4). Available at: http://www.ifcc.org/index.asp?cat=Publications&scat=eJIFCC_&suba=Vol_13_No_4&subx=Haemolysis_as_influence_and_interference_factor_-_English&zip=1&dove=1&zona=full&numero=&aq=1. Last accessed: 20 June 2011.
  • Ricós C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, Minchinela J, Perich C, Simón M. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491–500.
  • Hawkins RC. Poor knowledge and faulty thinking regarding hemolysis and potassium elevation. Clin Chem Lab Med 2005;43:216–220.
  • Frey AM. Drawing blood samples from vascular access devices: evidence-based practice. J Infus Nurs 2003;26:285–293.
  • Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589–1600.
  • Kasvosve I, Gomo ZA, Gangaidzo IT, Mvundura E, Saungweme T, Moyo VM, Khumalo H, Boelaert JR, Gordeuk VR, Delanghe JR. Reference range of serum haptoglobin is haptoglobin phenotype-dependent in blacks. Clin Chim Acta 2000;296:163–170.
  • Maniecki MB, Hasle H, Friis-Hansen L, Lausen B, Nielsen OJ, Bendix K, Moestrup SK, Møller HJ. Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin. Blood 2008;112:1510–1514.
  • Delanghe JR, Philippé J, Moerman F, De Buyzere ML, Vynckier LL, Verstraete AG, Vogelaers DP, Vandekerckhove L. Impaired hemoglobin scavenging during an acute HIV-1 retroviral syndrome. Clin Chim Acta 2010;411:521–523.
  • Lippi G, Franchini M, Salvagno GL, Guidi GC. Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci 2006;43:349–391.
  • Ma Z, Monk TG, Goodnough LT, McClellan A, Gawryl M, Clark T, Moreira P, Keipert PE, Scott MG. Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. Clin Chem 1997;43:1732–1737.
  • Kazmierczak SC, Catrou PG, Best AE, Sullivan SW, Briley KP. Multiple regression analysis of interference effects from a hemoglobin-based oxygen carrier solution. Clin Chem Lab Med 1999;37:453–464.
  • Cameron SJ, Gerhardt G, Engelstad M, Young MA, Norris EJ, Sokoll LJ. Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan. Clin Biochem 2009;42:221–224.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.